BioProtocol's PeptAI Peptide Design Fuels $BIO Token 96% Surge
The BioProtocol ($BIO) token experienced a significant price surge, jumping 96% in a single day and up to 118% over two days. This increase is primarily due to BioProtocol's PeptAI successfully designing a peptide agonist. The development highlights activity within the DeSCI platform and market rotation towards small-cap tokens.
Detected & updated continuously · Source: Ruma
Mentioned
Bio Protocol (bio)Sources
@bongbongcrypto
현재 기준 이틀만에 118%가 떡상해버린 이유 DeSCI 플랫폼인 @BioProtocol 에서 나온 PeptAI가 펩타이드 작용제를 설계한 사례 때문. 1. 제약 산업의 속도와 비용 추월 가능성 - 전통 제약사는 $50M + 2~3년의 연구비용 - BIO/ACC는 4~6주 + $500~$1500 으로 해결 가능하다고 제시 2. ADHD 치료에는 https://t.co/jE81ycBiH0
@Teambuertrades
$Bio did some magic and almost 8x my gains. https://t.co/TFI8zYwEX1
@KuCoin_Web3
#Crypto Market Snapshot (24h) - BIO surged 96% in a single day as small-cap tokens saw notable rotation. - $ENJ surged 50% in a short squeeze, while overheated token RAVE retraced 40%. Top 5 Gainers 1️⃣ $BIO 2️⃣ $TIME 3️⃣ $WHITEWHALE 4️⃣ $ORDI 5️⃣ $XPRT https://t.co/Hellbgdl2e